DKSH has signed an agreement to acquire Taqkey Science and Quantum Biotech in Taiwan, enhancing its position in the life sciences sector across Asia.

Target Information

DKSH has officially entered into an agreement to acquire two Taiwanese companies, Taqkey Science and Quantum Biotech. Taqkey, established in 2002 and headquartered in Miaoli, Taiwan, specializes in the distribution of life science reagents and consumables. Together with Quantum, the two companies employ over 60 staff members and generate annual net sales exceeding CHF 13 million. Taqkey boasts a robust portfolio comprised of long-standing relationships with prominent clients in the life sciences sector, facilitated through seven sales offices and three warehouses located across Taiwan.

This acquisition aligns DKSH’s strategic objectives to expand its scientific solutions and consumables segment within the Asia-Pacific region. By integrating Taqkey and Quantum into its operations, DKSH seeks to enhance its offerings in molecular biology, genetic engineering, and cell-based therapies, further reinforcing its position as a leading provider of scientific solutions in the region.

Industry Overview

The life science industry in Taiwan has experienced substantial growth over the past few years, driven by increasing investments in biotechnology and pharmaceuticals. Taiwan’s commitment to advancing healthcare innovation and fostering research ca